Navigation Links
Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis

: justify">

“This is a significant milestone for us. We are encouraged by the positive results from this study, which suggest HMPL-004 can be a novel class of anti-inflammatory drug for the treatment of Ulcerative Colitis. We believe that HMPL-004 has significant potential to bring patients another option for the treatment of this chronic, painful and frequently recurring disease, which may lead to abdominal surgery. We are looking forward to further clinical studies to fully evaluate the clinical benefits of HMPL-004. Today’s announcement further validates our new drug discovery and development capability and will also further accelerate recruitment in the on-going Phase II Crohn’s Disease trial in the US.”

Mr. Christian Hogg, CEO of Chi-Med, said:

“We are extremely pleased with the trial results, which fully meet our expectations. Ulcerative Colitis and Crohn’s Disease are core focus areas of our R&D programme, and we also look forward to the delivery of the Phase II results for HMPL-004 in Crohn’s Disease after which we would seek to out-license this product, in line with our stated strategy. Today’s results once more also highlight the potential of Traditional Chinese Medicine to provide a reservoir for innovative new drugs for the global pharmaceutical market.”

Ends

Enquiries
Chi-Med
Christian Hogg, CEO
Telephone: +852 2121 8200

Citigate Dewe Rogerson
Anthony Carlisle
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... 2014 EcoHealth Alliance, a nonprofit organization that focuses ... comprehensive review today examining the current state of knowledge ... calls for improved global surveillance strategies to combat the ... of Ebola in West Africa that has claimed the ... and Liberia. According to the World Health Organization ...
(Date:4/17/2014)... potential to ward off depression among retirees, particularly among ... in The Journals of Gerontology, Series B: ... article " Internet Use and Depression Among Retired Older ... the authors report that Internet use reduced the probability ... study sample. , Late-life depression affects between 5 ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
(Date:4/17/2014)... April 17, 2014 Meaningful long-term survival is ... of the abdomen when treated with cytoreductive surgery ... a first-of-its-size analysis by physicians at Wake Forest ... the largest reported, single-center experience with cytoreductive surgery ... M.D., and analysis of 20 years, worth of ...
Breaking Medicine News(10 mins):Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... ... commode or bedpan. Results from an independent laboratory study found that the Sani-Bag+ demonstrates ... ... reduces the potential for transmission of harmful bacteria and spores from human waste to ...
... Popular birth control ... Morgan & Morgan are alerting consumers of these side effects and reviewing possible lawsuits. ... (PRWEB) February 24, 2010 ... users of the birth control pills Yaz, Yasmin, and Ocella who have suffered serious side ...
... ... cues in the walking path can improve walking for movement disorder patients. A study performed ... visual cue chosen. , ... Israel (PRWEB) FEB 24, 2010 -- Visual feedback has been found in numerous studies to ...
... ... ... , , ... LOS ANGELES , ...
... ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Study Shows Sani-Bag+ to be an Effective Microbial Barrier 2Health News:Morgan & Morgan's Personal Injury Attorneys Provide Information About Yaz, Yasmin, and Ocella Injuries and Potential Health Risks 2Health News:Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained 2Health News:Court Orders Reinstatement of Vital, Cost-Saving Treatment for Children With Autism 2Health News:Court Orders Reinstatement of Vital, Cost-Saving Treatment for Children With Autism 3Health News:Gold's Gym and Us Weekly Join Forces to Present The First-Ever Hollywood's Hottest Body Awards 2Health News:Gold's Gym and Us Weekly Join Forces to Present The First-Ever Hollywood's Hottest Body Awards 3Health News:Gold's Gym and Us Weekly Join Forces to Present The First-Ever Hollywood's Hottest Body Awards 4Health News:Gold's Gym and Us Weekly Join Forces to Present The First-Ever Hollywood's Hottest Body Awards 5Health News:Gold's Gym and Us Weekly Join Forces to Present The First-Ever Hollywood's Hottest Body Awards 6Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 2Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 3Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 4Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 5Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 6Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 7Health News:Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010 8
... the cornea for centration of the flap and ... and enhancement cases. The corneal marker has a ... alignment of the flap after treatment. The spatula ... and to flood it back into place following ...
Duckbilled spatula designed to enter a side-port stab incision with tip broad enough to efficiently manipulate the lens nucleus in the anterior chamber. Spatula is useful for rotating and cracking th...
Short handled spatula for use through the side port stab incision. The malleable silver 0.5 mm tip can be shaped to the surgeon's preference for maximum control. Round serrated handle....
... to enter a side-port stab incision ... manipulate the lens nucleus in the ... rotating and cracking the nucleus. It ... and curved shaft which facilitates nuclear ...
Medicine Products: